DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/cf8nw2/infectious) has announced the addition of the "Infectious Disease Diagnostics Market by Product, Application, Technology, End User - Global Forecast to 2019" report to their offering.
The infectious disease diagnostics market is expected to grow at CAGR of 7.9% to reach $18.15 billion by 2019 from $12.42 billion in 2014
Increasing Prevalence of Deadly Infectious Disease and Need For Highly Specific and Sensitive Technologies for Rapid Diagnosis to Drive Growth of the IDD Market
The immunodiagnostics and polymerase chain reaction technology segments accounted for the lion's share of the global IDD market by technology, owing to growing need for advanced technologies for rapid diagnosis of infectious diseases.
On the basis of application, the IDD market is categorized into the Hepatitis B, Hepatitis C, Human Immunodeficiency Virus (HIV), Tuberculosis (TB), Chlamydia trachomatis and Neisseria gonorrhoeae (CT/NG), human papillomavirus (HPV), methicillin-resistant Staphylococcus aureus (MRSA), and others (Influenza, Ebola, Typhoid, Malaria, and Dengue, among others). Hospital-acquired MRSA infections, human papillomavirus, and AIDS are expected to be new revenue pockets in the applications market. The rising prevalence of these diseases globally is the major factor driving the growth of the aforementioned markets.
On the basis of product, the IDD market is segmented into instruments, consumables (reagents and assays), and software & services. Among products, consumables are estimated to be the fastest-growing market owing to its growing adoption in emerging infectious disease diagnostics worldwide.
On the basis of end user, the market is segmented into hospital laboratories, reference labs, physician's office labs, academics, and others (blood banks, local public health laboratories, home health agencies, nursing homes, point of care, self-testing). Hospital laboratories are expected to be the fastest-growing market in the forecast period. Owing to the complexity and highly specialized nature of diagnostic tests for infectious diseases, hospital laboratories are expected to grow at the fastest rate in the forecast period, from 2014 to 2019.
Key Topics Covered:
1 Introduction
2 Research Methodology
3 Executive Summary
4 Premium Insights
5 Market Overview
6 Industry Insights
7 Infectious Disease Diagnostics Market, By Product
8 Infectious Disease Diagnostics Market, By Application
9 Infectious Disease Diagnostics Market, By Technique
10 Infectious Disease Diagnostics Market, By End User
11 Geographic Analysis
12 Competitive Landscape
13 Company Profiles
- Abbott Laboratories
- Alere, Inc.
- Becton, Dickinson & Co.
- Bio-Rad Laboratories
- Biomérieux
- Danaher Corporation
- Johnson and Johnson
- Roche Diagnostics
- Siemens Healthcare
- Thermo Fisher Scientific, Inc.
For more information visit http://www.researchandmarkets.com/research/cf8nw2/infectious
